Presentation Information
[DGP2-05]DG2025-85: Omics Analysis in Clinical Trial
*Makoto Yamazaki1, Tatsuya Ikehara2, Toshiki Ueda3, Hiroyuki Shimizu4, Takuya Nagao5 (1. Tanabe Pharma Corporation, 2. Shionogi & Co., Ltd., 3. Chugai Pharmaceutical Co., Ltd., 4. Santen Pharmaceutical Co., Ltd., 5. Osaka International Cancer Institute)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in